financetom
Business
financetom
/
Business
/
Ferguson Enterprises Fiscal Q3 Adjusted Earnings, Sales Increase; Fiscal 2025 Sales Growth Outlook Lifted
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ferguson Enterprises Fiscal Q3 Adjusted Earnings, Sales Increase; Fiscal 2025 Sales Growth Outlook Lifted
Jun 3, 2025 4:49 AM

07:22 AM EDT, 06/03/2025 (MT Newswires) -- Ferguson Enterprises ( FERG ) reported fiscal Q3 adjusted earnings Tuesday of $2.50 per diluted share, up from $2.32 a year earlier.

Sales for the fiscal quarter ended April 30 were $7.62 billion, up from $7.31 billion a year earlier.

Analysts surveyed by FactSet expected $7.42 billion.

For fiscal 2025, the plumbing and heating products company upgraded its projected sales outlook to low to mid single-digit growth from low single-digit previously.

Analysts polled by FactSet expect organic sales growth of 1.78%.

Ferguson shares were up 8.2% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Saratoga Investment fiscal Q2 Adjusted Net Investment Income, Revenue Rise -- Shares Jump
Saratoga Investment fiscal Q2 Adjusted Net Investment Income, Revenue Rise -- Shares Jump
Oct 8, 2024
05:12 PM EDT, 10/08/2024 (MT Newswires) -- Saratoga Investment ( SAR ) advanced 9% in Tuesday's extended session after reporting fiscal Q2 adjusted net investment income of $1.33 per diluted share compared with $1.08 a year earlier. Analysts estimates for net investment income were not available on Capital IQ. Revenue for the quarter ended Aug. 31 was $43 million, compared...
Soleno Therapeutics Says US FDA Determines NDA for DCCR Does Not Need Advisory Panel Meeting for Now
Soleno Therapeutics Says US FDA Determines NDA for DCCR Does Not Need Advisory Panel Meeting for Now
Oct 8, 2024
09:12 AM EDT, 10/08/2024 (MT Newswires) -- Soleno Therapeutics ( SLNO ) said Tuesday that the US Food and Drug Administration has determined there is no need at this time for an advisory committee meeting for its new-drug application for extended-release tablets of diazoxide choline, or DCCR, to treat Prader-Willi syndrome. Soleno said that despite the determination, the FDA's Review...
Rezolve AI And Microsoft Power Up Retail With Advanced AI: A $30 Trillion Opportunity Unveiled
Rezolve AI And Microsoft Power Up Retail With Advanced AI: A $30 Trillion Opportunity Unveiled
Oct 8, 2024
Rezolve AI Limited ( RZLV ) confirmed that their ongoing collaboration with Microsoft Corporation ( MSFT ) will focus on delivering advanced AI solutions to enhance the global retail sector, which presents a $30 trillion market opportunity.  Last week, Rezolve partnered with Microsoft ( MSFT ) to distribute its AI-powered Brain Suite via Microsoft Azure Marketplace. This partnership combines Resolve AI’s Brain...
Citi hires LaVoie from Wells Fargo to head West Coast private equity M&A
Citi hires LaVoie from Wells Fargo to head West Coast private equity M&A
Oct 8, 2024
Oct 8 (Reuters) - Investment banker John LaVoie is joining Citigroup ( C/PN ) to head up its U.S. West Coast private equity dealmaking unit, according to an internal memo seen by Reuters on Tuesday. LaVoie, who has covered buyout firms for 24 years, will be based in San Francisco and report to Michael Marcus and Michael Quadrino, who are...
Copyright 2023-2026 - www.financetom.com All Rights Reserved